This announcement is a separate document:
AbbVie | 8-K: Abbvie Appointed Jennifer Davis as a Class II Director and Susan Quaggin as a Class III Director
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.